StockWatch
·

Eiko Lifesciences Ltd Q1 FY27 Results

EIKOQ1 FY27 Results
Filing
Result:Good· Market: Flat#Margin squeeze#Base effect
MetricValue (₹ Cr)Q4 FY26Q1 FY26
Revenue16.758.7%56.4%
Total Income17.167.1%56.3%
Expenditure15.207.5%59.9%
PBT1.964.1%33.2%
Net Profit1.510.7%35.0%
OPM11.57%0.89pp2.54pp
NPM8.79%0.68pp1.39pp
EPS0.912.1%37.9%
View full financials

Revenue grew a strong 56% YoY and PAT rose 35%, but OPM/NPM both compressed meaningfully (OPM 14.1%→11.6%), so core profitability quality lags the topline growth for this chemicals name.

Informational and educational content only. Not investment advice.